Prior studies have noted that GPX4 is highly expressed in hepatocellular carcinoma and colon cancer and that high GPX4 expression is a poor prognostic factor in diffuse large B-cell lymphoma and lung adenocarcinoma [19,20]. Here, GPX4 is linked to malignant colon neoplasm.